Clinical
Clinical Pipeline
Our clinical-stage pipeline includes product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.
Click on the potential products in the chart for compound information.
Click on the pipeline arrow for clinical information on each trial.
| IND-Enabling Studies | Safety/Dosing Studies | Efficacy Studies | Registration Studies | |
| Cancer Programs | ||||
| Azixa™ (MPC-6827) Melanoma |
 |
|||
| Azixa GBM |
 |
|||
| MPC-3100 Cancer |
 |
|||
| HIV Program | ||||
| MPC-4326 |
 |
|||
